[Clinical Applications of Circulating Tumor DNA in Response Evaluation and Relapse Monitoring of Primary Mediastinal Large B-Cell Lymphoma].
CtDNA may be combined with PET/CT to assess efficacy, monitor relapse, and guide treatment of PMBCL.
Authors
- Sichu Liu (ORCID: https://orcid.org/0000-0003-0004-9472)
- Hanguo Guo
- Fei-Li Chen
- Yan Teng (ORCID: https://orcid.org/0000-0003-3817-6696)
- Ning Wang (ORCID: https://orcid.org/0000-0002-4389-2796)
- Wenyu Li (ORCID: https://orcid.org/0000-0002-6444-7149)
- Lu Pan (ORCID: https://orcid.org/0009-0007-8994-6722)
- Ling Huang (ORCID: https://orcid.org/0000-0002-5373-7394)
- Xiaojuan Wei
- Xinmiao Jiang
- Zhanli Liang
Institutions
- Guangdong Academy of Medical Sciences (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.014
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article